Invex Therapeutics Limited (ASX:IXC) Announces Positive Exenatide Results
Invex Therapeutics Limited (ASX:IXC) reports significant findings on Exenatide’s efficacy in neuronal cell survival using a 3D brain model for Alzheimer’s Disease.
Invex Therapeutics Limited (ASX:IXC) reports significant findings on Exenatide’s efficacy in neuronal cell survival using a 3D brain model for Alzheimer’s Disease.
Aura Energy (ASX:AEE) has reported a 49% increase in Ore Reserves to 62.8Mt at the Tiris Uranium Project, enhancing project viability.
4DMedical Limited (ASX:4DX) has secured a contract with University of Chicago Medicine to enhance lung imaging and care.
INOVIQ Limited (ASX:IIQ) announces successful proof of concept for exosome therapy targeting breast cancer.
Aurora Energy Metals (ASX:1AE) announces significant uranium recovery improvements in its Aurora Uranium Project, achieving rates over 85%.
Venus Metals Corporation (ASX: VMC) reports promising exploration results from Copper Hills and Youanmi projects.
Maximus Resources Limited (ASX:MXR) completes follow-up drill program at Eagles Nest gold deposit; assay results expected in January 2025.
Anatara Lifesciences pauses recruitment for the GaRP-IBS trial, with pivotal results expected in March 2025 and a Share Purchase Plan closing soon.
Oncosil Medical Ltd completes a $1 million Share Purchase Plan to finance clinical trials and manufacturing improvements.
Lunnon Metals Limited (ASX:LM8) announces positive drilling results from Lady Herial, confirming significant gold mineralisation and enhancing its resource outlook.